PRESS RELEASE published on 04/13/2026 at 07:00, 6 months 15 days ago Inside Information / Other news releases Innate Pharma releases total shares and voting rights as of April 9, 2026, in compliance with French regulations. Learn about its innovative immunotherapies for cancer patients Voting Rights Shares French Regulations Innate Pharma Immunothérapies
BRIEF published on 04/03/2026 at 07:05, 6 months 25 days ago Innate Pharma will participate in the Kempen Life Sciences Conference Biotechnology Conference Innate Pharma Immunothérapies Kempen Life Sciences
BRIEF published on 04/03/2026 at 07:05, 6 months 25 days ago Innate Pharma to Join Kempen Life Sciences Conference Biotechnology Investor Meetings Innate Pharma Cancer Immunotherapies Kempen Conference
BRIEF published on 04/03/2026 at 07:05, 6 months 25 days ago Innate Pharma participera à la Kempen Life Sciences Conference Conference Innate Pharma Biotechnologies Immunothérapies Kempen Life Sciences
BRIEF published on 04/03/2026 at 07:05, 6 months 25 days ago Innate Pharma participera à la conférence Kempen Life Sciences Biotechnologie Innate Pharma Réunions Avec Les Investisseurs Conférence De Kempen Immunothérapies Contre Le Cancer
PRESS RELEASE published on 04/03/2026 at 07:00, 6 months 25 days ago Inside Information / Other news releases Innate Pharma to participate in the Kempen Life Sciences Conference on April 15-16, 2026, in Amsterdam, Netherlands. The company is developing immunotherapies for cancer patients Biotechnology Innate Pharma Immunothérapies Cancer Patients Kempen Life Sciences Conference
PRESS RELEASE published on 04/03/2026 at 07:00, 6 months 25 days ago Informations privilégiées / Autres communiqués Innate Pharma participera à la conférence Kempen Life Sciences à Amsterdam, Pays-Bas, du 15 au 16 avril 2026, pour présenter ses traitements d'immunothérapies contre le cancer Conference Immunothérapie Cancer Innate Pharma Kempen Life Sciences
BRIEF published on 12/11/2025 at 07:05, 10 months 17 days ago Innate Pharma révèle son calendrier financier 2026 Biotechnologie Calendrier Financier Immunothérapie Innate Pharma Résultats 2026
BRIEF published on 12/11/2025 at 07:05, 10 months 17 days ago Innate Pharma annonce son calendrier financier pour 2026 Biotechnologie Calendrier Financier Informations Pour Les Investisseurs Innate Pharma Dates Clés De 2026
BRIEF published on 12/11/2025 at 07:05, 10 months 17 days ago Innate Pharma reveals its 2026 financial calendar Biotechnology Financial Calendar Immunotherapy Innate Pharma 2026 Results
Published on 10/28/2026 at 12:30, 23 minutes ago Digi Power X to Announce 2026 Q3 Financial Results and Provide Operations Update on November 13th
Published on 10/28/2026 at 12:30, 23 minutes ago AI/ML Innovations Announces Advance Notice Provisions
Published on 10/28/2026 at 12:30, 23 minutes ago Sterling Expands Mineralized Footprint to 2km With Near Surface Intercept in 850m Eastern Step Out
Published on 10/28/2026 at 12:30, 23 minutes ago Ameriwest Reports Additional High-Grade Copper Results from Historical Drill Core at Bornite Including 71.0 Feet (21.6 Meters) at 8.08% CuEq
Published on 10/28/2026 at 12:15, 38 minutes ago BULGOLD Expands Strategic Exploration Position Around the Lutila Gold Project with Two New Exploration Licences
Published on 10/28/2026 at 12:24, 28 minutes ago EQS-Adhoc: Ad-hoc | IVU Traffic Technologies AG: Earnings for the first nine months of 2026 were significantly higher than the previous year; full-year guidance reiterated
Published on 10/28/2026 at 12:21, 32 minutes ago HELIOS SOLAR AG Postpones Publication of Audited Annual and Consolidated Financial Statements as of 30 June 2026
Published on 10/28/2026 at 12:05, 47 minutes ago Bloomberg Introduces BQuant Assistant to Help Financial Professionals Accelerate Data Analysis and Coding Workflows
Published on 10/28/2026 at 11:49, 1 hour 3 minutes ago OHB and Astroscale sign agreement to strengthen international cooperation on space security and orbital services capabilities
Published on 10/28/2026 at 11:34, 1 hour 18 minutes ago Logwin reports strong first nine-month results and updates outlook for 2026
Published on 10/28/2026 at 08:00, 4 hours 52 minutes ago Edenred successfully raises €800 million in a dual-tranche bond offering
Published on 10/28/2026 at 08:00, 4 hours 52 minutes ago Edenred lève avec succès 800 millions d’euros dans le cadre d’une émission obligataire à deux tranches
Published on 10/27/2026 at 18:00, 18 hours 53 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 18 hours 53 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
